| Stephen Michael Patrick, PA-C | |
|
2000 Eoff St, Wheeling, WV 26003-3823 | |
| (304) 234-0123 | |
| Not Available |
| Full Name | Stephen Michael Patrick |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 20 Years |
| Location | 2000 Eoff St, Wheeling, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124109533 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 01098 (West Virginia) | Secondary |
| 363AS0400X | Physician Assistant - Surgical | 01098 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reynolds Memorial Hospital | Glen dale, WV | Hospital |
| Wheeling Hospital | Wheeling, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reynolds Memorial Hospital, Inc | 9830184530 | 122 |
News Archive
The latest research into finding medications to aid the passage of ureteral or kidney stones has shown that tamsulosin is not effective for patients across the board.
The process for preparing frozen, par-fried potato strips - distributed to some food outlets for making french fries - can influence the formation of acrylamide in the fries that people eat, a new study has found. Published in ACS' Journal of Agricultural and Food Chemistry, the study identifies potential ways of reducing levels of acrylamide, which the National Toxicology Program and the International Agency for Research on Cancer regard as a "probable human carcinogen."
A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at Duke Cancer Institute is part of an effective, two-drug strategy for enlisting the immune system to fight tumors, according to a Duke-led study in Clinical Cancer Research, a journal of the American Association for Cancer Research.
University of California, Irvine researchers reveal how an ancient flavoprotein response to ultra violet (UV), blue and red light informs internal circadian processes about the time of day.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Michael Patrick, PA-C 2000 Eoff St, Wheeling, WV 26003-3823 Ph: (304) 234-8663 | Stephen Michael Patrick, PA-C 2000 Eoff St, Wheeling, WV 26003-3823 Ph: (304) 234-0123 |
News Archive
The latest research into finding medications to aid the passage of ureteral or kidney stones has shown that tamsulosin is not effective for patients across the board.
The process for preparing frozen, par-fried potato strips - distributed to some food outlets for making french fries - can influence the formation of acrylamide in the fries that people eat, a new study has found. Published in ACS' Journal of Agricultural and Food Chemistry, the study identifies potential ways of reducing levels of acrylamide, which the National Toxicology Program and the International Agency for Research on Cancer regard as a "probable human carcinogen."
A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at Duke Cancer Institute is part of an effective, two-drug strategy for enlisting the immune system to fight tumors, according to a Duke-led study in Clinical Cancer Research, a journal of the American Association for Cancer Research.
University of California, Irvine researchers reveal how an ancient flavoprotein response to ultra violet (UV), blue and red light informs internal circadian processes about the time of day.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has received a Complete Response Letter (CRL) for the New Drug Application (NDA) for ILUVIEN® from the U.S. Food and Drug Administration (FDA).
› Verified 1 days ago
Ms. Chelsea W Hewitt, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 76 16th Street, Wheeling, WV 26003 Phone: 304-238-0212 Fax: 304-238-0215 | |
Ms. Tonda Marie Stauffer, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 30 Medical Park, Suite 230, Wheeling, WV 26003 Phone: 304-242-4660 Fax: 304-242-6430 | |
Mrs. Wendy Sue Allenby, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 30 Medical Park, Suite 233, Wheeling, WV 26003 Phone: 304-242-9560 Fax: 304-242-4840 | |
Brittney J Sobota, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Medical Park, Wheeling Hospital Inc, Wheeling, WV 26003 Phone: 304-243-3000 Fax: 304-243-1038 | |
Katie Lynn Bolduc, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2101 Chapline St, Wheeling, WV 26003 Phone: 304-233-3240 Fax: 304-232-6128 | |
Michelle R Wolfe, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Medical Park, Wheeling Hospital Inc, Wheeling, WV 26003 Phone: 304-243-3124 | |
Mary Viola Rankin, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Medical Park, Wheeling Hospital Inc, Wheeling, WV 26003 Phone: 304-243-3124 |